This funding supports research projects aimed at closing the treatment gap for alcohol use disorder (AUD). Key focus areas include increasing treatment access and appeal, studying cost and insurance factors, disseminating evidence-based treatments, and reducing health disparities among affected populations. The mechanism is an R34 Clinical Trial Optional, encouraging innovative approaches to improve AUD health services.
Eligible applicants include a wide range of organizations such as state and local governments, nonprofits, for-profit organizations, tribal governments, educational institutions, and federal agencies. Both domestic and certain non-domestic entities may apply.
